✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Two samples were identified as anti-HCV positive (0.9 %).
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Randomly chosen blood samples from 218 healthy blood donors, attending Izmir State Hospital Blood Bank were tested for anti-HCV antibody using a commercial Ortho HCV Antibody ELISA Test System.
📊
Key Findings & Data:Randomly chosen blood samples from 218 healthy blood donors, attending Izmir State Hospital Blood Bank were tested for anti-HCV antibody using a commercial Ortho HCV Antibody ELISA Test System.
💡
Conclusion & Impact:Two samples were identified as anti-HCV positive (0.9 %).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Randomly chosen blood samples from 218 healthy blood donors, attending Izmir State Hospital Blood Bank were tested for anti-HCV antibody using a commercial Ortho HCV Antibody ELISA Test System. Two samples were identified as anti-HCV positive (0.9 %).
Özet
Izmir Devlet Hastanesi Kan Bankasi'na gelen ve rastgele seçilen sağlıklı 218 kan vericiden alınan kan örnekleri ticari Ortho HCV Antikor ELISA Test Sistemi kullanılarak incelendi, iki örnek anti-HCV pozitif olarak saptandı (% 0.9).
🔖
Cite This Article
KIPICI, A., SÜRÜCÜOĞLU, S., TÜRKER, M., BARAN, N. (2022). Kan vericilerinde hepatit C antikorlarının prevalansı. İnfeksiyon Dergisi, Cilt: 11 - Sayı: 2, 131–132. https://ajindex.com/articles/547126